Motivation after eXercise in Chronic Kidney Disease

Motivation after Exercise in Chronic Kidney Disease: randomised feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN57743249

Enrollment

Registered

2014-07-03

Start date

2014-06-25

Completion date

Unknown

Last updated

2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease Urological and Genital Diseases

Interventions

Participants will be randomised to normal clinical care or a motivational intervention. The motivational intervention will be a face to face session lasting approximately 45 minutes. The session wil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Established chronic kidney disease (Stages 3b-5) 2. Completed the ExTra CKD study protocol

Exclusion criteria

Exclusion criteria: 1. Age 9%), advanced cerebral or peripheral vascular disease) 3. Insufficient command of English to give informed consent or comply with the testing and training protocol. If the results indicate that the intervention is useful, future larger studies will include provision for those whose first language is not English.

Design outcomes

Primary

Measure	Time frame
Endurance Shuttle Walk Test (ESWT) a measure of physical capacity or endurance fitness. This will be measured at 6 and 12 weeks.	—

Secondary

Measure	Time frame
1. Quadriceps muscle size: 3D Ultrasonography. Measured at 6 weeks and 12 weeks 2. Physical function: Incremental shuttle walk test; sit to stand tests. Measured at 6 weeks and 12 weeks. 3. Daily physical activity: 7 day accelerometry. Measured at 5 weeks and 11 weeks 4. Body composition: Weight, height, waist circumference. Measured at 6 weeks and 12 weeks 5. Arterial stiffness: Pulse wave velocity. Measured at baseline, 6 weeks and 12 weeks 6. Clinical parameters: Extracted from medical records. Measured at 6 weeks and 12 weeks 7. Plasma markers of inflammation and oxidative stress, venous blood sample. Measured at 6 weeks and 12 weeks 8. Quality of Life: SF36 and EQ5D questionnaires. Measured at 6 weeks and 12 weeks 9. Symptom perception: Chronic Kidney Disease Symptom Score. Measured at 6 weeks and 12 weeks 10. Physical Activity habits and attitudes: Leicester Kidney Patient Physical Activity Questionnaire (comprising Duke Activity Status Index; GP Physical Activity Questionnaire; Leisure Time Exercise Questionnaire; Stage of Change Questionnaire; Self Efficacy Questionnaire). Measured at 6 weeks, and 12 weeks 11. Fatigue: FACIT-Fatigue Questionnaire & Visual Analogue Scale. Measured at baseline, 6 weeks, and 12 weeks 12. Appetite: Visual Analogue Scale. Measured at baseline, 6 weeks, 12 weeks, 18 weeks 13. Health care usage: measured weekly 14. Self-reported physical activity and intensity: measured daily 15: Patient satisfaction of intervention: measured at 12 weeks. 16: Patient experiences of exercise intervention: explored during first 6 weeks 17: Patient experiences of motivational intervention: explored at 12 weeks.	—

Measure

Time frame

1. Quadriceps muscle size: 3D Ultrasonography. Measured at 6 weeks and 12 weeks 2. Physical function: Incremental shuttle walk test; sit to stand tests. Measured at 6 weeks and 12 weeks. 3. Daily physical activity: 7 day accelerometry. Measured at 5 weeks and 11 weeks 4. Body composition: Weight, height, waist circumference. Measured at 6 weeks and 12 weeks 5. Arterial stiffness: Pulse wave velocity. Measured at baseline, 6 weeks and 12 weeks 6. Clinical parameters: Extracted from medical records. Measured at 6 weeks and 12 weeks 7. Plasma markers of inflammation and oxidative stress, venous blood sample. Measured at 6 weeks and 12 weeks 8. Quality of Life: SF36 and EQ5D questionnaires. Measured at 6 weeks and 12 weeks 9. Symptom perception: Chronic Kidney Disease Symptom Score. Measured at 6 weeks and 12 weeks 10. Physical Activity habits and attitudes: Leicester Kidney Patient Physical Activity Questionnaire (comprising Duke Activity Status Index; GP Physical Activity Questionnaire; Leisure Time Exercise Questionnaire; Stage of Change Questionnaire; Self Efficacy Questionnaire). Measured at 6 weeks, and 12 weeks 11. Fatigue: FACIT-Fatigue Questionnaire & Visual Analogue Scale. Measured at baseline, 6 weeks, and 12 weeks 12. Appetite: Visual Analogue Scale. Measured at baseline, 6 weeks, 12 weeks, 18 weeks 13. Health care usage: measured weekly 14. Self-reported physical activity and intensity: measured daily 15: Patient satisfaction of intervention: measured at 12 weeks. 16: Patient experiences of exercise intervention: explored during first 6 weeks 17: Patient experiences of motivational intervention: explored at 12 weeks.

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026